Clinical Trial Update: Plasma Determination of Glucagon-like Peptide 2 as a Predictor of Recovery in Adults With Acute Intestinal Failure

View source ↗

Summary

A completed clinical trial evaluated plasma glucagon-like peptide 2 as a predictor of recovery in adults with short bowel syndrome and acute intestinal failure.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intestinal Failure
• Short Bowel Syndrome

Snippet

Sponsor: Imperial College London | Conditions: Short Bowel Syndrome | Status: COMPLETED